Trademark Overview
On Saturday, August 20, 2022, a trademark application was filed for NORMGENE with the United States Patent and Trademark Office. The USPTO has given the NORMGENE trademark a serial number of 97557151. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 12, 2023. This trademark is owned by Ampel, LLC. The NORMGENE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical diagnostic test strips, patches, reagents and assays to analyze gene expression profiles in blood samples to assess whether an individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health
Medical testing services, namely, analyzing gene expression profiles in blood samples to assess whether an individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health; Medical information services, namely, providing medical information based on an individual's gene expression profile as to whether such individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health
